156 related articles for article (PubMed ID: 2355569)
1. [Anti-Scl-70 antibody and anti-nucleolar antibody in patients with systemic sclerosis].
Kinoshita M
Nihon Rinsho; 1990 Feb; 48 Suppl():494-6. PubMed ID: 2355569
[No Abstract] [Full Text] [Related]
2. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
[TBL] [Abstract][Full Text] [Related]
3. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
[TBL] [Abstract][Full Text] [Related]
4. Determination of anti-Scl-70 antibody and its clinical significance in progressive systemic sclerosis.
Jiang M; Song QF; Wang SZ; Yuan X; Zhang NZ
Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(4):247-9. PubMed ID: 3124097
[No Abstract] [Full Text] [Related]
5. Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.
Albon S; Bunn C; Swana G; Karim Y
J Immunol Methods; 2011 Feb; 365(1-2):126-31. PubMed ID: 21184759
[TBL] [Abstract][Full Text] [Related]
6. [Unusual manifestation of scleroderma of the trunk].
Hackel H; Zillikens D; Lechner W; Burg G
Hautarzt; 1990 Feb; 41(2):91-3. PubMed ID: 2180858
[TBL] [Abstract][Full Text] [Related]
7. [The Scl-70 antibody and its clinical significance].
Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
Dermatol Monatsschr; 1989; 175(3):133-47. PubMed ID: 2653887
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary manifestation of progressive systemic scleroderma: prognostic value of centromere antibodies and antibodies to Scl-70 nucleoprotein].
Behr J; König G; Meurer M; Krieg T
Pneumologie; 1990 Jun; 44(6):822-5. PubMed ID: 2381889
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
Reimer G
Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
[TBL] [Abstract][Full Text] [Related]
11. [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma].
Johanet C; Agostini MM; Vayssairat M; Abuaf N
Presse Med; 1989 Feb; 18(5):207-11. PubMed ID: 2522207
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of anti-nucleolar antibodies detected by immunoprecipitation method in patients with systemic sclerosis].
Kuwana M; Mimori T; Hama N; Kaburaki J; Okano T; Tojo T
Ryumachi; 1992 Feb; 32(1):39-46. PubMed ID: 1604415
[TBL] [Abstract][Full Text] [Related]
13. [Is there a place of multiantigenes immunodot determination in systemic sclerosis patients without anti-centromeres or anti-Scl70 antibodies?].
Sautereau N; Gabsi A; Daumas A; Bardin N; Granel B
Presse Med; 2015 May; 44(5):547-9. PubMed ID: 25813097
[No Abstract] [Full Text] [Related]
14. Scleroderma: DR antigens, autoantibodies and clinical manifestations.
Alarcón GS; McCarty GA; Lanyon P; Phillips RM; Acton RT; Barger BO
Clin Exp Rheumatol; 1987; 5(4):317-21. PubMed ID: 3326691
[TBL] [Abstract][Full Text] [Related]
15. [The PM-Scl (polymyositis-scleroderma) autoantibody and its nucleolar fluorescence pattern].
Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
Dermatol Monatsschr; 1989; 175(8):479-83. PubMed ID: 2676628
[TBL] [Abstract][Full Text] [Related]
16. [Antinuclear antibodies in progressive systemic sclerosis].
Sepúlveda C; Palma S; Guzmán L; Bravo M
Rev Med Chil; 1986 Aug; 114(8):731-6. PubMed ID: 3554436
[No Abstract] [Full Text] [Related]
17. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies.
Reveille JD; Solomon DH;
Arthritis Rheum; 2003 Jun; 49(3):399-412. PubMed ID: 12794797
[No Abstract] [Full Text] [Related]
18. [Serology in patients with scleroderma].
Ullman S; Halberg P; Høier-Madsen M; Kang L; Konstantinov K; Pedersen K; Rasmussen E; Wiik A
Ugeskr Laeger; 1993 Feb; 155(7):472-6. PubMed ID: 8465453
[TBL] [Abstract][Full Text] [Related]
19. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus.
Gussin HA; Ignat GP; Varga J; Teodorescu M
Arthritis Rheum; 2001 Feb; 44(2):376-83. PubMed ID: 11229469
[TBL] [Abstract][Full Text] [Related]
20. [Antibodies to extractable nuclear antigen polypeptides: detection and its clinical significance].
Xu YH
Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):541-3, 573. PubMed ID: 1338517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
